In contrast, D-Arg and D-NMMA – enantiomers that are inactive at NOS – had no effect; therefore, the blocking of myopia-prevention by NOS inhibitors is likely due to the stereospecific actions of these L-Arg analogs at NOS, rather than non-specific effects of arginine-like compounds via other molecular targets and processes27. Here, NOS2 is linked to myopia.